Shattuck Labs, Inc.
Key Metrics
Market Snapshot
About
Shattuck Labs is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine. The company focuses on cancer immunotherapy, designing molecules that simultaneously inhibit checkpoint pathways and stimulate immune responses. Their proprietary Agonist Redirected Checkpoint platform aims to overcome limitations of traditional cancer treatments.